RxDoctor Payments Data

Jim Savage, MD

Internal Medicine · San Francisco, CANPI 1891813416

Payments from drug & device makers

$1,278in general payments, 2019–2025

Across 81 payments — averaging $15.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arbor Pharmaceuticals, Inc.$933
  • Viiv Healthcare Company$114
  • Amarin Pharma, Inc.$108
  • GSK$50
  • AbbVie$33
  • Paratek Pharmaceuticals, Inc.$23
  • plus $16 from 1 others

What the payments were for

  • Food & beverage$1,26199%
  • Education$171%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,278 in reported general payments places this provider in the 75th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California

Medicare billing

Part B allowed, 2024
$23,911
Medicare patients
46
Services billed
183

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EdarbiAzilsartan Medoxomil19$9,661
Testosterone34$5,782
Celecoxib12$3,728
ArexvyRsvpref3 Antigen/As01e/Pf11$3,327
Rosuvastatin Calcium67$3,297
ShingrixVaricella-Zoster Ge/As01b/Pf14$3,076
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$1,468
Irbesartan24$534
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$502
Omeprazole12$341
Zolpidem Tartrate30$333
ValacyclovirValacyclovir Hcl11$328
Atorvastatin Calcium16$243
Amlodipine Besylate27$168
Eszopiclone14$160

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Arbor Pharmaceuticals, Inc.Edarbi$933$9,66119 claims
GSKArexvy, Shingrix$50$6,40325 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 13,581 internal medicine providers in California.

Other internal medicine in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →